Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia

Autor: Kostapanos, Michael S., Milionis, Haralampos J., Lagos, Konstantinos G., Rizos, Christos B., Tselepis, Alexandros D., Elisaf, Moses S.
Zdroj: In European Journal of Pharmacology 2008 590(1):327-332
Databáze: ScienceDirect